Total Payments
$6,457
2023 Payments
$1,798
Companies
60
Transactions
467
Medicare Patients
2,488
Medicare Billing
$199,597
Payment Breakdown by Category
Food & Beverage$6,329 (98.0%)
Education$128.37 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,329 | 457 | 98.0% |
| Education | $128.37 | 10 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $924.37 | 69 | $0 (2023) |
| Novo Nordisk Inc | $622.46 | 49 | $0 (2023) |
| Allergan, Inc. | $440.66 | 38 | $0 (2020) |
| PFIZER INC. | $426.56 | 43 | $0 (2023) |
| Lilly USA, LLC | $338.85 | 23 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $323.51 | 20 | $0 (2023) |
| Amgen Inc. | $224.22 | 15 | $0 (2023) |
| Astellas Pharma US Inc | $213.47 | 9 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $194.92 | 18 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $171.58 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,798 | 135 | ABBVIE INC. ($299.52) |
| 2022 | $1,087 | 66 | ABBVIE INC. ($353.35) |
| 2021 | $1,093 | 77 | AbbVie Inc. ($256.86) |
| 2020 | $637.33 | 46 | Allergan, Inc. ($112.16) |
| 2019 | $1,073 | 81 | Allergan Inc. ($190.62) |
| 2018 | $574.57 | 48 | Allergan Inc. ($107.58) |
| 2017 | $194.86 | 14 | Novo Nordisk Inc ($34.60) |
All Payment Transactions
467 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Diabetes Care | ||||||
| 12/21/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: PAIN | ||||||
| 12/14/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Genetic Disease | ||||||
| 12/11/2023 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Obesity | ||||||
| 12/07/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: UROLOGY | ||||||
| 12/07/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: PAIN | ||||||
| 12/06/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Diabetes | ||||||
| 12/05/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Central Nervous System | ||||||
| 12/01/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Diabetes Care | ||||||
| 12/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Neurology | ||||||
| 11/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Diabetes | ||||||
| 11/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Obesity | ||||||
| 11/15/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.53 | General |
| Category: PAIN | ||||||
| 11/14/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: PAIN | ||||||
| 11/10/2023 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: UROLOGY | ||||||
| 10/31/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.21 | General |
| Category: PAIN | ||||||
| 10/30/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Diabetes | ||||||
| 10/27/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 504 | 948 | $102,663 | $44,398 |
| 2022 | 15 | 599 | 1,334 | $113,588 | $45,194 |
| 2021 | 15 | 702 | 1,620 | $132,739 | $56,123 |
| 2020 | 15 | 683 | 1,822 | $135,518 | $53,883 |
Total Patients
2,488
Total Services
5,724
Medicare Billing
$199,597
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 337 | $61,272 | $27,943 | 45.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 159 | $19,331 | $6,552 | 33.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 21 | 21 | $4,110 | $2,488 | 60.5% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 21 | 22 | $5,016 | $2,186 | 43.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 23 | 23 | $3,890 | $1,744 | 44.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 105 | 189 | $1,512 | $1,482 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 27 | $1,186 | $806.82 | 68.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 38 | 87 | $3,954 | $735.10 | 18.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 26 | 44 | $2,158 | $332.65 | 15.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 21 | 39 | $234.00 | $129.58 | 55.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 130 | 364 | $43,821 | $20,202 | 46.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 107 | $19,177 | $7,120 | 37.1% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 51 | 122 | $16,089 | $5,647 | 35.1% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 51 | 142 | $12,233 | $4,396 | 35.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 28 | 28 | $3,698 | $1,967 | 53.2% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Office | 2022 | 26 | 26 | $4,644 | $1,747 | 37.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 38 | 106 | $4,835 | $939.47 | 19.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 32 | 32 | $1,344 | $882.71 | 65.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 13 | 17 | $1,309 | $863.00 | 65.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 17 | $1,212 | $505.74 | 41.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 88 | 170 | $1,578 | $503.31 | 31.9% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 16 | 23 | $1,217 | $183.32 | 15.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 18 | 31 | $230.00 | $104.01 | 45.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 18 | 25 | $1,250 | $87.29 | 7.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 13 | 124 | $950.00 | $46.64 | 4.9% |
About Dr. Joseph Rakestraw, D.O
Dr. Joseph Rakestraw, D.O is a Family Medicine healthcare provider based in Jefferson City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922002864.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Rakestraw, D.O has received a total of $6,457 in payments from pharmaceutical and medical device companies, with $1,798 received in 2023. These payments were reported across 467 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($6,329).
As a Medicare-enrolled provider, Rakestraw has provided services to 2,488 Medicare beneficiaries, totaling 5,724 services with total Medicare billing of $199,597. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Jefferson City, MO
- Active Since 06/09/2005
- Last Updated 09/17/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1922002864
Products in Payments
- UBRELVY (Drug) $523.42
- VRAYLAR (Drug) $347.47
- NURTEC ODT (Drug) $229.68
- Ozempic (Drug) $223.82
- FARXIGA (Drug) $178.58
- QULIPTA (Drug) $177.75
- XARELTO (Drug) $168.23
- XIFAXAN (Drug) $160.60
- JARDIANCE (Drug) $156.26
- MYRBETRIQ (Drug) $142.06
- LINZESS (Drug) $134.91
- CHANTIX (Drug) $129.40
- MOUNJARO (Drug) $118.56
- Rybelsus (Drug) $118.05
- SPIRIVA RESPIMAT (Drug) $90.49
- FREESTYLE LIBRE 3 (Device) $90.28
- TRINTELLIX (Drug) $88.98
- BYSTOLIC (Drug) $87.28
- ELIQUIS (Drug) $86.66
- Victoza (Drug) $84.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Jefferson City
Dr. George Carr, Md, MD
Family Medicine — Payments: $45,033
Family Medicine $45,033
Dr. Eric Caywood, D.o, D.O
Family Medicine — Payments: $17,382
Family Medicine $17,382
Dustin Warbritton, D.o, D.O
Family Medicine — Payments: $13,272
Family Medicine $13,272
Benjamin Cook, Do, DO
Family Medicine — Payments: $9,154
Family Medicine $9,154
Dr. Michael Steenbergen, M.d, M.D
Family Medicine — Payments: $9,039
Family Medicine $9,039
Dr. Saira Babar, M.d, M.D
Family Medicine — Payments: $7,055
Family Medicine $7,055